<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Thorac Med</journal-id><journal-id journal-id-type="iso-abbrev">Ann Thorac Med</journal-id><journal-id journal-id-type="publisher-id">ATM</journal-id><journal-title-group><journal-title>Annals of Thoracic Medicine</journal-title></journal-title-group><issn pub-type="ppub">1817-1737</issn><issn pub-type="epub">1998-3557</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23437019</article-id><article-id pub-id-type="pmc">3573562</article-id><article-id pub-id-type="publisher-id">ATM-8-64a</article-id><article-id pub-id-type="doi">10.4103/1817-1737.105723</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letters to the Editor</subject></subj-group></article-categories><title-group><article-title>Diagnostic performance of interferon-Gamma assay for tuberculosis in immunocompromised patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Su</surname><given-names>Shih-Yang</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Chao</surname><given-names>Chien-Ming</given-names></name><xref ref-type="aff" rid="aff2">1</xref><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Lai</surname><given-names>Chih-Cheng</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1"><italic>Department of Emergency Medicine, Tainan Municipal Hospital, Liouying, Taiwan E-mail: <email xlink:href="dtmed141@gmail.com">dtmed141@gmail.com</email></italic></aff><aff id="aff2"><label>1</label><italic>Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Taiwan</italic></aff><aff id="aff3"><label>2</label><italic>Department of Nursing, Min-Hwei College of Health Care Management, Tainan, Taiwan</italic></aff><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2013</year></pub-date><volume>8</volume><issue>1</issue><fpage seq="a">64</fpage><lpage>64</lpage><permissions><copyright-statement>Copyright: &#x000a9; Annals of Thoracic Medicine</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions></article-meta></front><body><p>Sir,</p><p>We read with great interest a recent article by Eldin <italic>et al</italic>. who investigated the utility of interferon (INF)-&#x003b3; level and Quantiferon-TB Gold In tube (QFT-GIT) assay for the diagnosis of pleural tuberculosis (TB).[<xref ref-type="bibr" rid="ref1">1</xref>] They concluded the <italic>ex vivo</italic> pleural fluid INF-&#x003b3; levels is an accurate diagnostic tool for pleural TB.[<xref ref-type="bibr" rid="ref1">1</xref>]</p><p>However, the immune status of the patients in this study was not shown, and we wonder whether the immunocompromised condition would affect the performance of these tests or not. In fact, the role of QFT-GIT for pulmonary TB in immunocompromised patients remains questionable.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref3">3</xref>] In the study in Korea, Jung <italic>et al</italic>. enrolled 119 immunocompromised patients, which included 29 patients with diabetes mellitus, 53 with malignancy, 23 with taking immunosuppressive drugs, and 14 with end-stage renal disease, and found sensitivity and specificity (95% CI) were: (59.0% (44.9-72.0)) and (61.3% (54.4-67.6)) of QFT-GIT for diagnosing smear-negative pulmonary TB.[<xref ref-type="bibr" rid="ref2">2</xref>] As well as in a previous study by Lai <italic>et al</italic>. in Taiwan,[<xref ref-type="bibr" rid="ref3">3</xref>] QFT-GIT assay had more indeterminate and false-negative results than another INF-&#x003b3; release assays (IGRA) &#x02013; an enzyme-linked immunospot assay (T-SPOT.TB assay), especially in immunocompromised patients.</p><p>Therefore, we would like to suggest that the author should mention the underlying condition &#x02013; immunocompetent or immunocompromised status &#x02013; in the description of the demographic characteristics to help reader better understand the background.</p></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eldin</surname><given-names>EN</given-names></name><name><surname>Omar</surname><given-names>A</given-names></name><name><surname>Khairy</surname><given-names>M</given-names></name><name><surname>Mekawy</surname><given-names>AH</given-names></name><name><surname>Ghanem</surname><given-names>MK</given-names></name></person-group><article-title>Diagnostic value of <italic>ex vivo</italic> pleural fluid interferon-gamma versus adapted whole-blood quantiferon-TB gold in tube assays in tuberculous pleural effusion</article-title><source>Ann Thorac Med</source><year>2012</year><volume>7</volume><fpage>220</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">23189099</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>JY</given-names></name><name><surname>Lim</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Cho</surname><given-names>SN</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Questionable role of interferon-&#x003b3; assays for smear-negative pulmonary TB in immunocompromised patients</article-title><source>J Infect</source><year>2012</year><volume>64</volume><fpage>188</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">22120597</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>CC</given-names></name><name><surname>Tan</surname><given-names>CK</given-names></name><name><surname>Lin</surname><given-names>SH</given-names></name><name><surname>Liao</surname><given-names>CH</given-names></name><name><surname>Huang</surname><given-names>YT</given-names></name><name><surname>Hsueh</surname><given-names>PR</given-names></name></person-group><article-title>Diagnostic performance of whole-blood interferon-&#x003b3; assay and enzyme-linked immunospot assay for active tuberculosis</article-title><source>Diagn Microbiol Infect Dis</source><year>2011</year><volume>71</volume><fpage>139</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">21840675</pub-id></element-citation></ref></ref-list></back></article>